Prostatitis: Diagnosis and treatment

American Family Physician

Volumn 82, Issue 4, 2010, Pages 397-406

  Sharp, Victoria J ^a   Takacs, Elizabeth B ^a   Powell, Charles R ^b  

^a UNIVERSITY OF IOWA HEALTH CARE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFUZOSIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; FINASTERIDE; GABAPENTIN; LEVOFLOXACIN; NORFLOXACIN; NORTRIPTYLINE; PENTOSAN POLYSULFATE; PREGABALIN; PROSTATE SPECIFIC ANTIGEN; QUERCETIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAMSULOSIN; ANTIINFECTIVE AGENT;

ACUTE BACTERIAL PROSTATITIS; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BEDTIME DOSAGE; CAUSAL ATTRIBUTION; CHILL; CHLAMYDIA TRACHOMATIS; CHRONIC PROSTATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG COST; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DYSURIA; ELECTROMYOGRAPHY; ENTEROCOCCUS; ESCHERICHIA COLI; FEVER; GRAM STAINING; HUMAN; INCIDENCE; KLEBSIELLA; MALAISE; MALE; NAUSEA; NEISSERIA GONORRHOEAE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PELVIS PAIN SYNDROME; PREVALENCE; PROSTATE SECRETION; PROSTATITIS; PROTEUS; PSEUDOMONAS; RESIDUAL URINE; SEMEN ANALYSIS; SEPSIS; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS; URINARY FREQUENCY; URINARY TRACT PAIN; URINARY URGENCY; URINE CULTURE; ACUTE DISEASE; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; MICROBIOLOGY; PAIN; REVIEW;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PAIN; PROSTATITIS;

EID: 77956402791     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Krieger JN, Lee SW, Jeon J, Cheah PY, Liong ML, Riley DE. Epidemiology of prostatitis. Int J Antimicrob Agents. 2008;31(suppl 1):S85-S90.
2. Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159(4):1224-1228.
3. Pontari MA, Joyce GF, Wise M, McNaughton-Collins M; Urologic Diseases in America Project. Prostatitis. J Urol. 2007;177(6):2050-2057.
4. McNaughton Collins M, Pontari MA, O'Leary MP, et al. Quality of life is impaired in men with chronic prostatitis: the Chronic Prostatitis Collaborative Research Network. J Gen Intern Med. 2001;16(10):656-662.
5. Nadler RB, Schaeffer AJ. Lower urinary tract cultures. In: Nickel JC, ed. Textbook of Prostatitis. Oxford, England: Isis Medical Media; 1999:201-206.
6. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;281(3):236-237.
7. Nickel JC, Shoskes D, Wang Y, et al. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol. 2006;176(1):119-124.
8. Budía A, Luis Palmero J, Broseta E, et al. Value of semen culture in the diagnosis of chronic bacterial prostatitis: a simplified method. Scand J Urol Nephrol. 2006;40(4):326-331.
9. Nickel JC. Recommendations for the evaluation of patients with prostatitis. World J Urol. 2003;21(2):75-81.
10. Naber KG. Antibiotic treatment of chronic bacterial prostatitis. In: Nickel JC, ed. Textbook of Prostatitis. Oxford, England: Isis Medical Media; 1999:285-292.
11. Naber KG, Wagenlehner FM, Weidner W. Acute bacterial prostatitis. In: Shoskes DA, ed. Current Clinical Urology Series, Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Totowa, N.J.: Humana Press; 2008:17-30.
12. Nickel JC, Costerton JW. Coagulase-negative staphylococcus in chronic prostatitis. J Urol. 1992;147(2):398-400.
13. Krieger JN, Ross SO, Limaye AP, Riley DE. Inconsistent localization of gram-positive bacteria to prostate-specific specimens from patients with chronic prostatitis. Urology. 2005;66(4):721-725.
14. Nickel JC. Inflammatory conditions of the male genitourinary tract: prostatitis and related conditions, orchitis, and epididymitis. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, eds. Campbell-Walsh Urology. 9th ed. Philadelphia, Pa.: Saunders; 2007:304-329.
15. Lipsky BA. Prostatitis and urinary tract infection in men: what's new; what's true? Am J Med. 1999;106(3):327-334.
16. Schaeffer AJ. NIDDK-sponsored Chronic Prostatitis Collaborative Research Network (CPCRN) 5-year data and treatment guidelines for bacterial prostatitis. Int J Antimicrob Agents. 2004;24(suppl 1):S49-S52.
17. Kravchick S, Cytron S, Agulansky L, Ben-Dor D. Acute prostatitis in middle-aged men: a prospective study. BJU Int. 2004;93(1):93-96.
18. Gilbert DN, Moellering RC, Eliopolous GM, Sande MA. The Sanford Guide to Antimicrobial Therapy. Sperryville, Va.: Antimicrobial Therapy; 2008.
19. Leport C, Rousseau F, Perronne C, Salmon D, Joerg A, Vilde JL. Bacterial prostatitis in patients infected with the human immunodeficiency virus. J Urol. 1989;141(2):334-336.
20. Feliciano J, Teper E, Ferrandino M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? J Urol. 2008;179(3):952-955.
21. Cox CE, Childs SJ. Treatment of chronic bacterial prostatitis with temafloxacin [published correction appears in Am J Med. 1992;92(4):454]. Am J Med. 1991;91(6A):134S-139S.
22. Naber KG, Madsen PO. Antibiotics: basic concepts. In: Nickel JC, ed. Textbook of Prostatitis. Oxford, England: Isis Medical Media; 1999:83-94.
23. Terai A, Ishitoya S, Mitsumori K, Ogawa O. Molecular epidemiological evidence for ascending urethral infection in acute bacterial prostatitis. J Urol. 2000;164(6):1945-1947.
24. Kirby RS, Lowe D, Bultitude MI, Shuttleworth KE. Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol. 1982;54(6):729-731.
25. Blacklock NJ. The anatomy of the prostate: relationship with prostatic infection. Infection. 1991;19(suppl 3):S111-S114.
26. Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, Sofikitis N. Penetration of antimicrobial agents into the prostate. Chemotherapy. 2003;49(6):269-279.
27. Nickel JC, Moon T. Chronic bacterial prostatitis: an evolving clinical enigma. Urology. 2005;66(1):2-8.
28. Heyns CF, Fisher M. The urological management of the patient with acquired immunodeficiency syndrome. BJU Int. 2005;95(5):709-716.
29. Schaeffer AJ. Clinical practice. Chronic prostatitis and the chronic pelvic pain syndrome. N Engl J Med. 2006;355(16):1690-1698.
30. Propert KJ, McNaughton-Collins M, Leiby BE, O'Leary MP, Kusek JW, Litwin MS; Chronic Prostatitis Collaborative Research Network. A prospective study of symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome: the National Institutes of Health Chronic Prostatitis Cohort study. J Urol. 2006;175(2):619-623.
31. Shoskes DA, Berger R, Elmi A, Landis JR, Propert KJ, Zeitlin S; Chronic Prostatitis Collaborative Research Network Study Group. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the Chronic Prostatitis Cohort Study. J Urol. 2008;179(2):556-560.
32. Schaeffer AJ, Knauss JS, Landis JR, et al.; Chronic Prostatitis Collaborative Research Network Study Group. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort Study. J Urol. 2002;168(3):1048-1053.
33. Nickel JC, Alexander RB, Schaeffer AJ, Landis JR, Knauss JS, Propert KJ; Chronic Prostatitis Collaborative Research Network Study Group. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol. 2003;170(3):818-822.
34. Nickel JC. Classification and diagnosis of prostatitis: a gold standard? Andrologia. 2003;35(3):160-167.
35. Nickel JC. Clinical evaluation of the patient presenting with prostatitis. Eur Urol Suppl. 2003;2(2):11-14.
36. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al.; Chronic Prostatitis Collaborative Research Network. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol. 1999;162(2):369-375.
37. Propert KJ, Litwin MS, Wang Y, et al.; Chronic Prostatitis Collaborative Research Network (CPCRN). Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res. 2006;15(2):299-305.
38. Habermacher GM, Chason JT, Schaeffer AJ. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med. 2006;57:195-206.
39. Alexander RB, Propert KJ, Schaeffer AJ, et al.; Chronic Prostatitis Collaborative Research Network. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med. 2004;141(8):581-589.
40. Nickel JC, Krieger JN, McNaughton-Collins M, et al.; Chronic Prostatitis Collaborative Research Network. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med. 2008;359(25):2663-2673.
41. Nickel JC, Forrest JB, Tomera K, et al. Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo-controlled study. J Urol. 2005;173(4):1252-1255.
42. Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). BJU Int. 2004;93(7):991-995.
43. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999;54(6):960-963.
44. Pontari MA. Chronic prostatitis/chronic pelvic pain syndrome. Urol Clin North Am. 2008;35(1):81-89.
45. Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol. 2003;60(11):1524-1534.
46. Clemens JQ, Nadler RB, Schaeffer AJ, Belani J, Albaugh J, Bushman W. Biofeedback, pelvic floor re-education, and bladder training for male chronic pelvic pain syndrome. Urology. 2000;56(6):951-955.
47. Schaeffer AJ, Datta NS, Fowler JE Jr, et al.; Chronic Prostatitis Collaborative Research Network. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Urology. 2002;60(6 suppl):1-4.
48. Fitzgerald MP, Anderson RU, Potts J, et al.; Urological Pelvic Pain Collaborative Research Network. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009;182(2):570-580.
49. Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int. 2004;93(6):777-779.
50. Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodríguez LV. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J. 2008;19(4):553-557.
51. Zeitlin SI. Heat therapy in the treatment of prostatitis. Urology. 2002;60(6 suppl):38-40.